Review Article
Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, et al. Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clin Infect Dis. 2019;69(2):197-203.
10.1093/cid/ciy99130452608PMC6603263Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13(3):371-384.
10.1128/CMR.13.3.37110885982Sommer C, Resch B, Simoes EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5:144-154.
10.2174/187428580110501014422262987PMC3258650Walter EB, Munoz FM. New Approaches to Respiratory Syncytial Virus Prevention and Treatment. Annu Rev Med. 2024.
10.1146/annurev-med-061323-07393439656962Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23(1):7-18.
10.1136/jcp.23.1.74909103PMC474401Carvajal JJ, Avellaneda AM, Salazar-Ardiles C, Maya JE, Kalergis AM, Lay MK. Host Components Contributing to Respiratory Syncytial Virus Pathogenesis. Front Immunol. 2019;10:2152.
10.3389/fimmu.2019.0215231572372PMC6753334Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007;195(8):1126-1136.
10.1086/51261517357048PMC7109876Ressel S, Kumar S, Bermúdez-Barrientos JR, Gordon K, Lane J, Wu J, et al. RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity. Nucleic Acids Res. 2024;52(9):4872-4888.
10.1093/nar/gkae11638412296PMC11109944Pei J, Beri NR, Zou AJ, Hubel P, Dorando HK, Bergant V, et al. Nuclear-localized human respiratory syncytial virus NS1 protein modulates host gene transcription. Cell Rep. 2021;37(2):109803.
10.1016/j.celrep.2021.10980334644581PMC8609347Rajan A, Piedra FA, Aideyan L, McBride T, Robertson M, Johnson HL, et al. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. 2022;96(7):e0190421.
10.1128/jvi.01904-2135285685PMC9006923Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Moller R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036-1045.e9.
10.1016/j.cell.2020.04.02632416070PMC7227586McAllister CS, Ansaldi D, Growcott EJ, Zhong Y, Quackenbush D, Wolff KC, et al. Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling. Virology. 2020;540:195-206.
10.1016/j.virol.2019.10.00731929001Mann MW, Fu Y, Gearhart RL, Xu X, Roberts DS, Li Y, et al. Bromodomain-containing Protein 4 regulates innate inflammation via modulation of alternative splicing. Front Immunol. 2023;14:1212770.
10.3389/fimmu.2023.121277037435059PMC10331468Xu X, Qiao D, Mann M, Garofalo RP, Brasier AR. Respiratory Syncytial Virus Infection Induces Chromatin Remodeling to Activate Growth Factor and Extracellular Matrix Secretion Pathways. Viruses. 2020;12(8):804.
10.3390/v1208080432722537PMC7472097Talukdar SN, Osan J, Ryan K, Grove B, Perley D, Kumar BD, et al. RSV-induced expanded ciliated cells contribute to bronchial wall thickening. Virus Res. 2023;327:199060.
10.1016/j.virusres.2023.19906036746339PMC10007709Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K, et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol. 2007;178(5):3134-3142.
10.4049/jimmunol.178.5.313417312161Huang YC, Li Z, Hyseni X, Schmitt M, Devlin RB, Karoly ED, et al. Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line. Genomic Med. 2008;2(3-4):113-125.
10.1007/s11568-009-9080-y19459069PMC2694865Spalluto CM, Singhania A, Cellura D, Woelk CH, Sanchez-Elsner T, Staples KJ, et al. IFN-γ Influences Epithelial Antiviral Responses via Histone Methylation of the RIG-I Promoter. Am J Respir Cell Mol Biol. 2017;57(4):428-438.
10.1165/rcmb.2016-0392OC28481620Wisgrill L, Martens A, Kasbauer R, Eigenschink M, Pummer L, Redlberger-Fritz M, et al. Network analysis reveals age- and virus-specific circuits in nasal epithelial cells of extremely premature infants. Allergy. 2024;79(11):3062-3081.
10.1111/all.1619638898695Anderson J, Imran S, Ng YY, Wang T, Ashley S, Thang C, et al. Differential anti-viral response to respiratory syncytial virus A in preterm and term infants. Ebiomedicine. 2024;102:105044.
10.1016/j.ebiom.2024.10504438447274PMC10933467Thornburg NJ, Shepherd B, Crowe JE Jr. Transforming Growth Factor Beta Is a Major Regulator of Human Neonatal Immune Responses following Respiratory Syncytial Virus Infection. J Virol. 2010;84(24):12895-12902.
10.1128/JVI.01273-1020926560PMC3004333Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, et al. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity. 2017;46(2):301-314.
10.1016/j.immuni.2017.01.01028228284PMC7128247Vissers M, Schreurs I, Jans J, Heldens J, de Groot R, de Jonge MI, et al. Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells. Cytokine. 2015;76(2):458-464.
10.1016/j.cyto.2015.07.02426253531Zivanovic N, Öner D, Abraham Y, McGinley J, Drysdale SB, Wildenbeest JG, et al. Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants. Clin Transl Med. 2023;13(12):e1507.
10.1002/ctm2.150738115705PMC10731116Mejias A, Dimo B, Suarez NM, Garcia C, Suarez-Arrabal MC, Jartti T, et al. Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection. Plos Med. 2013;10(11):e1001549.
10.1371/journal.pmed.100154924265599PMC3825655Dapat C, Kumaki S, Sakurai H, Nishimura H, Labayo HKM, Okamoto M, et al. Gene signature of children with severe respiratory syncytial virus infection. Pediatr Res. 2021;89(7):1664-1672.
10.1038/s41390-020-01347-933510411PMC8249238Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, et al. Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection. J Virol. 2012;86(10):5422-5436.
10.1128/JVI.06757-1122398282PMC3347264Heinonen S, Velazquez VM, Ye F, Mertz S, Acero-Bedoya S, Smith B, et al. Immune profiles provide insights into respiratory syncytial virus disease severity in young children. Sci Transl Med. 2020;12(540):eaaw0268.
10.1126/scitranslmed.aaw026832321862Yu JS, Peterson DR, Baran AM, Bhattacharya S, Wylie TN, Falsey AR, et al. Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection. J Infect Dis. 2019;219(7):1151-1161.
10.1093/infdis/jiy60830339221PMC6420164Wallihan RG, Suárez NM, Cohen DM, Marcon M, Moore-Clingenpeel M, Mejias A, et al. Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia. Front Cell Infect Microbiol. 2018;8:382.
10.3389/fcimb.2018.0038230425971PMC6218690Rodriguez-Fernandez R, Tapia LI, Yang CF, Torres JP, Chavez-Bueno S, Garcia C, et al. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. J Infect Dis. 2017;217(1):24-34.
10.1093/infdis/jix54329045741PMC5853407Do LAH, Pellet J, van Doorn HR, Tran AT, Nguyen BH, Tran TL, et al. Host Transcription Profile in Nasal Epithelium and Whole Blood of Hospitalized Children Under 2 Years of Age With Respiratory Syncytial Virus Infection. J Infect Dis. 2017;217(1):134-146.
10.1093/infdis/jix51929029245PMC5853303McDonald JU, Kaforou M, Clare S, Hale C, Ivanova M, Huntley D, et al. A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease. Msystems. 2016;1(3):e00051-16.
10.1128/mSystems.00051-1627822537PMC5069771de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, et al. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med. 2016;194(9):1104-1115.
10.1164/rccm.201602-0220OC27135599PMC5114450Brand HK, Ahout IM, de Ridder D, van Diepen A, Li Y, Zaalberg M, et al. Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection. PloS One. 2015;10(7):e0131927.
10.1371/journal.pone.013192726162090PMC4498630Herberg JA, Kaforou M, Gormley S, Sumner ER, Patel S, Jones KD, et al. Transcriptomic Profiling in Childhood H1N1/09 Influenza Reveals Reduced Expression of Protein Synthesis Genes. J Infect Dis. 2013;208(10):1664-1668.
10.1093/infdis/jit34823901082PMC3805235Habibi MS, Thwaites RS, Chang M, Jozwik A, Paras A, Kirsebom F, et al. Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection. Science. 2020;370(6513):eaba9301.
10.1126/science.aba930133033192PMC7613218Zaas AK, Chen M, Varkey J, Veldman T, Hero AO 3rd, Lucas J, et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe. 2009;6(3):207-217.
10.1016/j.chom.2009.07.00619664979PMC2852511Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science. 2005;309(5740):1577-1581.
10.1126/science.111332916141076Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A. 2012;109(3):941-946.
10.1073/pnas.111226310922215596PMC3271899Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, et al. Hepatitis C Virus RNA Functionally Sequesters miR-122. Cell. 2015;160(6):1099-1110.
10.1016/j.cell.2015.02.02525768906PMC4386883Scheel TK, Luna JM, Liniger M, Nishiuchi E, Rozen-Gagnon K, Shlomai A, et al. A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration. Cell Host Microbe. 2016;19(3):409-423.
10.1016/j.chom.2016.02.00726962949PMC4826034Altan-Bonnet G, Mukherjee R. Cytokine-mediated communication: a quantitative appraisal of immune complexity. Nat Rev Immunol. 2019;19(4):205-217.
10.1038/s41577-019-0131-x30770905PMC8126146Wen X, Ding L, Wang JJ, Qi M, Hammonds J, Chu H, et al. ROCK1 and LIM Kinase Modulate Retrovirus Particle Release and Cell-Cell Transmission Events. J Virol. 2014;88(12):6906-6921.
10.1128/JVI.00023-1424696479PMC4054354Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, et al. LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection. J Biol Chem. 2011;286(14):12554-12564.
10.1074/jbc.M110.18223821321123PMC3069457Xiang Y, Zheng K, Zhong M, Chen J, Wang X, Wang Q, et al. Ubiquitin-proteasome-dependent slingshot 1 downregulation in neuronal cells inactivates cofilin to facilitate HSV-1 replication. Virology. 2014;449:88-95.
10.1016/j.virol.2013.11.01124418541König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, et al. Human host factors required for influenza virus replication. Nature. 2010;463(7282):813-817.
10.1038/nature0869920027183PMC2862546Villalonga E, Mosrin C, Normand T, Girardin C, Serrano A, Zunar B, et al. LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. Cells. 2023;12(5):805.
10.3390/cells1205080536899941PMC10000741Yi F, Guo J, Dabbagh D, Spear M, He S, Kehn-Hall K, et al. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. J Virol. 2017;91(13).
10.1128/JVI.02418-1628381571PMC5469273Atreya PL, Peeples ME, Collins PL. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J Virol. 1998;72(2):1452-1461.
10.1128/JVI.72.2.1452-1461.19989445048PMC124626Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, et al. Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nat Microbiol. 2017;2(9):17101.
10.1038/nmicrobiol.2017.10128665409PMC5739881Zhang Y, Yang L, Wang H, Zhang G, Sun X. Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-α receptor. Biochem Bioph Res Commun. 2016;478(3):1436-1441.
10.1016/j.bbrc.2016.08.14227569280Zhang J, Jamaluddin M, Zhang Y, Widen SG, Sun H, Brasier AR, et al. Type II Epithelial-Mesenchymal Transition Upregulates Protein N-Glycosylation To Maintain Proteostasis and Extracellular Matrix Production. J Proteome Res. 2019;18(9):3447-3460.
10.1021/acs.jproteome.9b0034231424945PMC7195216Tian B, Patrikeev I, Ochoa L, Vargas G, Belanger KK, Litvinov J, et al. NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns. Am J Respir Cell Mol Biol. 2017;56(4):506-520.
10.1165/rcmb.2016-0259OC27911568PMC5449514Mehedi M, Collins PL, Buchholz UJ. A novel host factor for human respiratory syncytial virus. Commun Integr Biol. 2017;10(3):e1319025.
10.1080/19420889.2017.131902528702128PMC5501218Mehedi M, McCarty T, Martin SE, Le Nouen C, Buehler E, Chen YC, et al. Actin-Related Protein 2 (ARP2) and Virus-Induced Filopodia Facilitate Human Respiratory Syncytial Virus Spread. Plos Pathog. 2016;12(12):e1006062.
10.1371/journal.ppat.100606227926942PMC5142808Habibi MS, Jozwik A, Makris S, Dunning J, Paras A, DeVincenzo JP, et al. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. Am J Resp Crit Care Med. 2015;191(9):1040-1049.
10.1164/rccm.201412-2256OC25730467PMC4435460Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2015;6:10224.
10.1038/ncomms1022426687547PMC4703893- Publisher :The Korean Society for Microbiology and The Korean Society of Virology
- Publisher(Ko) :대한미생물학회‧대한바이러스학회
- Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
- Volume : 54
- No :4
- Pages :297-311
- Received Date : 2024-11-26
- Revised Date : 2024-12-20
- Accepted Date : 2024-12-24
- DOI :https://doi.org/10.4167/jbv.2024.54.4.297